At CARA Yakhteh, our clinical trials are designed to evaluate the safety and therapeutic potential of our autologous CAR T-cell therapies in carefully selected patient populations. By enrolling individuals who meet precise eligibility criteria, we ensure that our investigational treatments are assessed with scientific rigor—allowing us to generate meaningful data on efficacy, safety, and long-term outcomes in cancer care.